CLINICAL_TRIALS
trial_result
· 2008-06-17
Clinical Trial Update: High Intensity Focused Ultrasound (HIFU) Ablation System Study [Phase 3]
Summary
A Phase 3 study of ProRhythm's High Intensity Focused Ultrasound ablation system for atrial fibrillation has been suspended.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: ProRhythm, Inc. | Conditions: Atrial Fibrillation | Phase 3 | Status: SUSPENDED